Literature DB >> 18787211

Combinatorial incorporation of enhancer-blocking components of the chicken beta-globin 5'HS4 and human T-cell receptor alpha/delta BEAD-1 insulators in self-inactivating retroviral vectors reduces their genotoxic potential.

Ali Ramezani1, Teresa S Hawley, Robert G Hawley.   

Abstract

Insertional mutagenesis by retroviral vectors has emerged as a serious impediment to the widespread application of hematopoietic stem cell gene transfer for the treatment of hematologic diseases. Here we report the development of a 77-base pair element, FII/BEAD-A (FB), which contains the minimal enhancer-blocking components of the chicken beta-globin 5'HS4 insulator and a homologous region from the human T-cell receptor alpha/delta BEAD-1 insulator. With a new flow cytometry-based assay, we show that the FB element is as effective in enhancer-blocking activity as the prototypical 1.2-kilobase 5'HS4 insulator fragment. When incorporated into the residual U3 region of the 3' long terminal repeat (LTR) of a self-inactivating (SIN) gammaretroviral vector, the FB element was stably transferred to the 5' LTR during reverse transcription, flanking the integrated transgene expression cassette. Notably, using a recently established in vitro insertional mutagenesis assay involving primary murine hematopoietic cells, we found that SIN gammaretroviral vectors, as well as SIN lentiviral vectors, containing the FB element exhibited greatly reduced transforming potential-to background levels under the experimental conditions used-compared with their unshielded counterparts. These results suggest that the FB element-mediated enhancer-blocking modification is a promising approach to dramatically improve the safety of retroviral vectors for therapeutic gene transfer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18787211      PMCID: PMC2605779          DOI: 10.1634/stemcells.2008-0258

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  53 in total

1.  Characterization of the chicken beta-globin insulator.

Authors:  J H Chung; A C Bell; G Felsenfeld
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

2.  An enhancer-blocking element between alpha and delta gene segments within the human T cell receptor alpha/delta locus.

Authors:  X P Zhong; M S Krangel
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

3.  Efficient selection for high-expression transfectants with a novel eukaryotic vector.

Authors:  H Niwa; K Yamamura; J Miyazaki
Journal:  Gene       Date:  1991-12-15       Impact factor: 3.688

4.  Versatile retroviral vectors for potential use in gene therapy.

Authors:  R G Hawley; F H Lieu; A Z Fong; T S Hawley
Journal:  Gene Ther       Date:  1994-03       Impact factor: 5.250

5.  Handicapped retroviral vectors efficiently transduce foreign genes into hematopoietic stem cells.

Authors:  R G Hawley; L Covarrubias; T Hawley; B Mintz
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

6.  Retroviral activation of a novel gene encoding a zinc finger protein in IL-3-dependent myeloid leukemia cell lines.

Authors:  K Morishita; D S Parker; M L Mucenski; N A Jenkins; N G Copeland; J N Ihle
Journal:  Cell       Date:  1988-09-09       Impact factor: 41.582

7.  Thrombopoietic potential and serial repopulating ability of murine hematopoietic stem cells constitutively expressing interleukin 11.

Authors:  R G Hawley; T S Hawley; A Z Fong; C Quinto; M Collins; J P Leonard; S J Goldman
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

8.  A 5' element of the chicken beta-globin domain serves as an insulator in human erythroid cells and protects against position effect in Drosophila.

Authors:  J H Chung; M Whiteley; G Felsenfeld
Journal:  Cell       Date:  1993-08-13       Impact factor: 41.582

9.  Leukemia induction after a single retroviral vector insertion in Evi1 or Prdm16.

Authors:  U Modlich; A Schambach; M H Brugman; D C Wicke; S Knoess; Z Li; T Maetzig; C Rudolph; B Schlegelberger; C Baum
Journal:  Leukemia       Date:  2008-05-22       Impact factor: 11.528

10.  Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells.

Authors:  S F Yu; T von Rüden; P W Kantoff; C Garber; M Seiberg; U Rüther; W F Anderson; E F Wagner; E Gilboa
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

View more
  34 in total

1.  A self-inactivating lentiviral vector for SCID-X1 gene therapy that does not activate LMO2 expression in human T cells.

Authors:  Sheng Zhou; Disha Mody; Suk See DeRavin; Julia Hauer; Taihe Lu; Zhijun Ma; Salima Hacein-Bey Abina; John T Gray; Michael R Greene; Marina Cavazzana-Calvo; Harry L Malech; Brian P Sorrentino
Journal:  Blood       Date:  2010-05-10       Impact factor: 22.113

Review 2.  Genetic treatment of a molecular disorder: gene therapy approaches to sickle cell disease.

Authors:  Megan D Hoban; Stuart H Orkin; Daniel E Bauer
Journal:  Blood       Date:  2016-01-12       Impact factor: 22.113

3.  Preventing and exploiting the oncogenic potential of integrating gene vectors.

Authors:  Ute Modlich; Christopher Baum
Journal:  J Clin Invest       Date:  2009-04       Impact factor: 14.808

4.  Insertional transformation of hematopoietic cells by self-inactivating lentiviral and gammaretroviral vectors.

Authors:  Ute Modlich; Susana Navarro; Daniela Zychlinski; Tobias Maetzig; Sabine Knoess; Martijn H Brugman; Axel Schambach; Sabine Charrier; Anne Galy; Adrian J Thrasher; Juan Bueren; Christopher Baum
Journal:  Mol Ther       Date:  2009-08-11       Impact factor: 11.454

Review 5.  The use of chromatin insulators to improve the expression and safety of integrating gene transfer vectors.

Authors:  David W Emery
Journal:  Hum Gene Ther       Date:  2011-03-25       Impact factor: 5.695

6.  Factor VIII delivered by haematopoietic stem cell-derived B cells corrects the phenotype of haemophilia A mice.

Authors:  Ali Ramezani; Lynnsey A Zweier-Renn; Robert G Hawley
Journal:  Thromb Haemost       Date:  2011-01-25       Impact factor: 5.249

Review 7.  Development of gene therapy for thalassemia.

Authors:  Arthur W Nienhuis; Derek A Persons
Journal:  Cold Spring Harb Perspect Med       Date:  2012-11-01       Impact factor: 6.915

Review 8.  Biosafety features of lentiviral vectors.

Authors:  Axel Schambach; Daniela Zychlinski; Birgitta Ehrnstroem; Christopher Baum
Journal:  Hum Gene Ther       Date:  2013-02       Impact factor: 5.695

9.  Potentially therapeutic levels of anti-sickling globin gene expression following lentivirus-mediated gene transfer in sickle cell disease bone marrow CD34+ cells.

Authors:  Fabrizia Urbinati; Phillip W Hargrove; Sabine Geiger; Zulema Romero; Jennifer Wherley; Michael L Kaufman; Roger P Hollis; Christopher B Chambers; Derek A Persons; Donald B Kohn; Andrew Wilber
Journal:  Exp Hematol       Date:  2015-02-12       Impact factor: 3.084

10.  Does retroviral insertional mutagenesis play a role in the generation of induced pluripotent stem cells?

Authors:  Robert G Hawley
Journal:  Mol Ther       Date:  2008-08       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.